[1]
|
Seib, C.D. and Sosa, J.A. (2018) Evolving Understanding of the Epidemiology of Thyroid Cancer. Endocrinology and Metabolism Clinics of North America, 48, 23-35. https://doi.org/10.1016/j.ecl.2018.10.002
|
[2]
|
Luzón-Toro, B., Fernández, R., Villalba-Benito, L., et al. (2019) Influencers on Thyroid Cancer Onset: Molecular Genetic Basis. Genes, 10, 913-941. https://doi.org/10.3390/genes10110913
|
[3]
|
Perri, F., Giordano, A., Pisconti, S., et al. (2018) Thy-roid Cancer Management: From a Suspicious Nodule to Targeted Therapy. Anticancer Drugs, 29, 483-490. https://doi.org/10.1097/CAD.0000000000000617
|
[4]
|
Liu, Q., Pan, L.Z., Hu, M., et al. (2020) Molecular Net-work-Based Identification of Circular RNA-Associated ceRNA Network in Papillary Thyroid Cancer. Pathology and Oncology Research, 26, 1293-1299.
https://doi.org/10.1007/s12253-019-00697-y
|
[5]
|
Xu, X. and Jing, J. (2020) Advances on circRNAs Contribute to Carcinogenesis and Progression in Papillary Thyroid Carcinoma. Frontiers in Endocrinology (Lausanne), 11, Article ID: 555243.
https://doi.org/10.3389/fendo.2020.555243
|
[6]
|
Kristensen, L.S., Andersen, M.S., Stagsted, L.V.W., et al. (2019) The Biogenesis, Biology and Characterization of Circular RNAs. Nature Reviews. Genetics, 20, 675-691. https://doi.org/10.1038/s41576-019-0158-7
|
[7]
|
Thomson, D.W. and Dinger, M.E. (2016) Endogenous mi-croRNA Sponges: Evidence and Controversy. Nature Reviews. Genetics, 17, 272-283. https://doi.org/10.1038/nrg.2016.20
|
[8]
|
Kari, S., Vasko, V.V., Priya, S., et al. (2019) PKA Activates AMPK through LKB1 Signaling in Follicular Thyroid Cancer. Frontiers in Endocrinology (Lausanne), 10, Article No. 769. https://doi.org/10.3389/fendo.2019.00769
|
[9]
|
Zhang, Q., Xing, Y., Jiang, S., et al. (2020) Integrated Analysis Identifies DUSP5 as a Novel Prognostic Indicator for Thyroid Follicular Carcinoma. Thoracic Cancer, 11, 336-345. https://doi.org/10.1111/1759-7714.13270
|
[10]
|
Pitsava, G., Stratakis, C.A. and Faucz, F.R. (2021) PRKAR1A and Thyroid Tumors. Cancers (Basel), 13, Article No. 3834. https://doi.org/10.3390/cancers13153834
|
[11]
|
Gambardella, C., Offi, C., Patrone, R., et al. (2019) Calcitonin Nega-tive Medullary Thyroid Carcinoma: A Challenging Diagnosis or a Medical Dilemma? BMC Endocrine Disorders, 19, Article No. 45.
https://doi.org/10.1186/s12902-019-0367-2
|
[12]
|
Ceolin, L., Duval, M., Benini, A.F., et al. (2019) Medullary Thy-roid Carcinoma beyond Surgery: Advances, Challenges, and Perspectives. Endocrine-Related Cancer, 26, R499-R518. https://doi.org/10.1530/ERC-18-0574
|
[13]
|
Zheng, X., Rui, S., Wang, X.F., et al. (2021) circPVT1 Regulates Me-dullary Thyroid Cancer Growth and Metastasis by Targeting miR-455-5p to Activate CXCL12/CXCR4 Signaling. Jour-nal of Experimental & Clinical Cancer Research, 40, Article No. 157. https://doi.org/10.1186/s13046-021-01964-0
|
[14]
|
Li, A.Y., McCusker, M.G., Russo, A., et al. (2019) RET Fu-sions in Solid Tumors. Cancer Treatment Reviews, 81, Article ID: 101911. https://doi.org/10.1016/j.ctrv.2019.101911
|
[15]
|
Chatterjee, S. and Chakravarti, A. (2019) A Gene Regulatory Net-work Explains RET-EDNRB Epistasis in Hirschsprung Disease. Human Molecular Genetics, 28, 3137-3147. https://doi.org/10.1093/hmg/ddz149
|
[16]
|
Yue, C., Oner, M., Chiu, C., et al. (2021) RET Regulates Human Medul-lary Thyroid Cancer Cell Proliferation through CDK5 and STAT3 Activation. Biomolecules (Basel, Switzerland), 11, Ar-ticle No. 860.
https://doi.org/10.3390/biom11060860
|
[17]
|
Gebert, L.F.R. and MacRae, I.J. (2019) Regulation of microRNA Function in Animals. Nature Reviews. Molecular Cell Biology, 20, 21-37. https://doi.org/10.1038/s41580-018-0045-7
|
[18]
|
Han, Y., Liao, Q., Wang, H., et al. (2019) High Expression of Calreticulin Indicates Poor Prognosis and Modulates Cell Migration and Invasion via Activating Stat3 in Nasopharyngeal Carcinoma. Journal of Cancer, 10, 5460-5468.
https://doi.org/10.7150/jca.35362
|
[19]
|
Tang, J., Luo, Y. and Xiao, L. (2022) USP26 Promotes Anaplastic Thyroid Cancer Progression by Stabilizing TAZ. Cell Death & Disease, 13, Article No. 326. https://doi.org/10.1038/s41419-022-04781-1
|
[20]
|
Yang, J. and Barletta, J.A. (2020) Anaplastic Thyroid Carcinoma. Seminars in Diagnostic Pathology, 5, 248-256.
https://doi.org/10.1053/j.semdp.2020.06.005
|
[21]
|
Abe, I. and Lam, A.K. (2021) Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics. Current Oncology Reports, 23, Article No. 31. https://doi.org/10.1007/s11912-021-01019-9
|
[22]
|
Panebianco, F., Nikitski, A.V., Nikiforova, M.N., et al. (2019) Spectrum of TERT Promoter Mutations and Mechanisms of Activation in Thyroid Cancer. Cancer Medicine, 8, 5831-5839. https://doi.org/10.1002/cam4.2467
|
[23]
|
Jin, J., Shi, Y., Zhang, S., et al. (2020) PIK3CA Mutation and Clinicopathological Features of Colorectal Cancer: A Systematic Review and Meta-Analysis. Acta Oncologica, 59, 66-74. https://doi.org/10.1080/0284186X.2019.1664764
|
[24]
|
Du, X., et al. (2018) ALK-Rearrangement in Non-Small-Cell Lung Cancer (NSCLC). Thoracic Cancer, 9, 423-430.
https://doi.org/10.1111/1759-7714.12613
|
[25]
|
Vosgha, H., Ariana, A., Smith, R.A., et al. (2018) miR-205 Targets Angiogenesis and EMT Concurrently in Anaplastic Thyroid Carcinoma. Endocrine-Related Cancer, 25, 323-337. https://doi.org/10.1530/ERC-17-0497
|
[26]
|
Hu, J., Yuan, I.J., Mirshahidi, S., et al. (2021) Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy. International Journal of Mo-lecular Sciences, 22, Article No. 1950.
https://doi.org/10.3390/ijms22041950
|
[27]
|
Kim, B.H., et al. (2016) Recent Updates on the Management of Medul-lary Thyroid Carcinoma. Endocrinology and Metabolism (Seoul), 31, 392-399. https://doi.org/10.3803/EnM.2016.31.3.392
|